On the other hand, Aleanizy et al. described the use of nanocapsules containing G4 PAMAM polyamidoamine dendrimer with neratinib and attached to trastuzumab, which was characterized by increased cellular uptake in HER2+ breast cancer cells [29]. Here, ERBB2 is linked to breast cancer.